stockportfolio.pro
Achieve Life Sciences, Inc. (ACHV)
Healthcare · Biotechnology · NasdaqCM
Achieve Life Sciences, Inc. revenue & earnings — last 10 fiscal years
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross profit | — | — | — | — | — | — | — | — | — | — |
| Net income | $-1.23M | $-10.58M | $-12.69M | $-16.39M | $-14.73M | $-33.15M | $-42.35M | $-29.82M | $-39.83M | $-54.65M |
| Net margin | — | — | — | — | — | — | — | — | — | — |
Source: Achieve Life Sciences, Inc. SEC filings (10-K). 17 years of history available in the interactive view.
Explore 17 years of Achieve Life Sciences, Inc. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track ACHV in your portfolio →
Achieve Life Sciences, Inc. financial history by metric
About Achieve Life Sciences, Inc.
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.
Achieve Life Sciences, Inc. — frequently asked questions
What is Achieve Life Sciences, Inc.'s revenue?
Achieve Life Sciences, Inc. (ACHV) reported revenue of $0 for fiscal year 2025, according to its SEC filings.
Is Achieve Life Sciences, Inc. profitable?
No — ACHV reported a net loss of $-54.65M in fiscal 2025.
What is ACHV's P/E ratio?
Achieve Life Sciences, Inc. trades at a price-to-earnings ratio of about 0.0 based on the latest data in our nightly-refreshed cache.
How much debt does Achieve Life Sciences, Inc. have?
As of fiscal year 2025, ACHV carried roughly $14.89M in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is Achieve Life Sciences, Inc.'s market cap?
Achieve Life Sciences, Inc. (ACHV) has a market capitalization of about $627.25M, based on the latest data in our nightly-refreshed cache.
When does Achieve Life Sciences, Inc.'s fiscal year end?
ACHV's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.
Where does this data come from?
All figures are computed from Achieve Life Sciences, Inc.'s official SEC filings (10-K and 10-Q), covering 17 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.